Chargement en cours...

An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin

PURPOSE: The aim of this study was to investigate the efficacy and tolerability of switching from 0.2 mg tamsulosin to 0.4 mg tamsulosin oral controlled absorption system (OCAS) over a 12-week period in Taiwanese men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplas...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Interv Aging
Auteurs principaux: Yang, Pei-Shan, Chen, Chien-Lun, Hou, Chen-Pang, Lin, Yu-Hsiang, Tsui, Ke-Hung
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808696/
https://ncbi.nlm.nih.gov/pubmed/29445269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S152701
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!